141 related articles for article (PubMed ID: 2748532)
1. Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide.
Shah JC; Chen JR; Chow D
Pharm Res; 1989 May; 6(5):408-12. PubMed ID: 2748532
[TBL] [Abstract][Full Text] [Related]
2. Enhancement and modification of etoposide release from crospovidone particles loaded with oil-surfactant blends.
Boltri L; Coceani N; De Curto D; Dobetti L; Esposito P
Pharm Dev Technol; 1997 Nov; 2(4):373-81. PubMed ID: 9552466
[TBL] [Abstract][Full Text] [Related]
3. Metastable polymorph of etoposide with higher dissolution rate.
Shah JC; Chen JR; Chow D
Drug Dev Ind Pharm; 1999 Jan; 25(1):63-7. PubMed ID: 10028419
[TBL] [Abstract][Full Text] [Related]
4. Stability-indicating high-performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column.
Chow D; Shah J; Chen JR
J Chromatogr; 1987 Jun; 396():217-23. PubMed ID: 3624372
[TBL] [Abstract][Full Text] [Related]
5. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery.
Fan Y; Yang M; Wang Y; Li Y; Zhou Y; Chen X; Shan L; Wei J; Gao C
Drug Dev Ind Pharm; 2015 May; 41(5):801-11. PubMed ID: 24694186
[TBL] [Abstract][Full Text] [Related]
6. [Determination of equilibrium solubility and n-octanol/water partition coefficient of pulchinenosiden D by HPLC].
Rao XY; Yin S; Zhang GS; Luo XJ; Jian H; Feng YL; Yang SL
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1593-6. PubMed ID: 25095367
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and biopharmaceutical characterization of BTA-243, a diacidic drug with low oral bioavailability.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2001 Feb; 213(1-2):127-34. PubMed ID: 11165100
[TBL] [Abstract][Full Text] [Related]
8. Solubility, stability and ionization behaviour of famotidine.
Islam MS; Narurkar MM
J Pharm Pharmacol; 1993 Aug; 45(8):682-6. PubMed ID: 7901363
[TBL] [Abstract][Full Text] [Related]
9. Preformulation studies of a novel HIV protease inhibitor, AG1343.
Longer M; Shetty B; Zamansky I; Tyle P
J Pharm Sci; 1995 Sep; 84(9):1090-3. PubMed ID: 8537887
[TBL] [Abstract][Full Text] [Related]
10. Preformulation studies on the S-isomer of oxybutynin hydrochloride, an Improved Chemical Entity (ICE).
Luner PE; Kirsch LE; Majuru S; Oh E; Joshi AB; Wurster DE; Redmon MP
Drug Dev Ind Pharm; 2001 Apr; 27(4):321-9. PubMed ID: 11411899
[TBL] [Abstract][Full Text] [Related]
11. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
12. Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion.
Tian L; He H; Tang X
J Pharm Sci; 2007 Jul; 96(7):1719-28. PubMed ID: 17503537
[TBL] [Abstract][Full Text] [Related]
13. Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics.
Kim JH; Lee SK; Lim JL; Shin HJ; Hong CI
Int J Pharm; 2002 Jun; 239(1-2):207-11. PubMed ID: 12052706
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of bergenin.
Zhou D; Qin X; Zhang ZR; Huang Y
Pharmazie; 2008 May; 63(5):366-71. PubMed ID: 18557421
[TBL] [Abstract][Full Text] [Related]
15. Preformulation studies of myricetin: a natural antioxidant flavonoid.
Yao Y; Lin G; Xie Y; Ma P; Li G; Meng Q; Wu T
Pharmazie; 2014 Jan; 69(1):19-26. PubMed ID: 24601218
[TBL] [Abstract][Full Text] [Related]
16. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
Tammara VK; Narurkar MM; Crider AM; Khan MA
J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties of amphoteric beta-lactam antibiotics I: Stability, solubility, and dissolution behavior of amino penicillins as a function of pH.
Tsuji A; Nakashima E; Hamano S; Yamana T
J Pharm Sci; 1978 Aug; 67(8):1059-66. PubMed ID: 27624
[TBL] [Abstract][Full Text] [Related]
18. Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization.
Singh G; Pai RS
Expert Opin Drug Deliv; 2014 Jul; 11(7):1023-32. PubMed ID: 24820316
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological attempts to improve the bioavailability of oral etoposide.
Joel SP; Clark PI; Heap L; Webster L; Robbins S; Craft H; Slevin ML
Cancer Chemother Pharmacol; 1995; 37(1-2):125-33. PubMed ID: 7497581
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
